CIRRUS LOGIC, INC., 10-Q filed on 2/2/2023
Quarterly Report
v3.22.4
Cover - shares
 9 Months Ended
Dec. 24, 2022
Jan. 31, 2023
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Dec. 24, 2022  
Document Transition Report false  
Entity File Number 0-17795  
Entity Registrant Name CIRRUS LOGIC, INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 77-0024818  
Entity Address, Address Line One 800 W. 6th Street  
Entity Address, City or Town Austin,  
Entity Address, State or Province TX  
Entity Address, Postal Zip Code 78701  
City Area Code (512)  
Local Phone Number 851-4000  
Title of 12(b) Security Common stock, $0.001 par value  
Trading Symbol CRUS  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   55,257,165
Amendment Flag false  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q3  
Current Fiscal Year End Date --03-25  
Entity Central Index Key 0000772406  
v3.22.4
Consolidated Condensed Balance Sheets - USD ($)
$ in Thousands
Dec. 24, 2022
Mar. 26, 2022
Current assets:    
Cash and cash equivalents $ 434,544 $ 369,814
Marketable securities 28,373 10,601
Accounts receivable, net 270,493 240,264
Inventories 152,426 138,436
Prepaid assets 38,881 40,822
Other current assets 88,768 40,078
Total current assets 1,013,485 840,015
Long-term marketable securities 44,784 63,749
Right-of-use lease assets 150,938 171,003
Property and equipment, net 156,602 157,077
Intangibles, net 133,032 158,145
Goodwill 435,936 435,791
Deferred tax assets 8,630 11,068
Long-term prepaid wafers 154,575 195,000
Other assets 67,907 91,552
Total assets 2,165,889 2,123,400
Current liabilities:    
Accounts payable 117,406 115,417
Accrued salaries and benefits 42,187 65,261
Software license agreements 22,543 21,736
Current lease liabilities 14,024 14,680
Acquisition-related liabilities 18,195 30,964
Other accrued liabilities 14,194 16,725
Total current liabilities 228,549 264,783
Long-term liabilities:    
Non-current lease liabilities 143,252 163,162
Non-current income taxes 72,267 73,383
Long-term acquisition-related liabilities 0 8,692
Software license agreements 5,501 13,563
Total long-term liabilities 221,020 258,800
Stockholders' equity:    
Capital stock 1,639,056 1,578,427
Accumulated earnings 80,865 23,435
Accumulated other comprehensive loss (3,601) (2,045)
Total stockholders' equity 1,716,320 1,599,817
Total liabilities and stockholders' equity $ 2,165,889 $ 2,123,400
v3.22.4
Consolidated Condensed Statements Of Income - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Dec. 24, 2022
Dec. 25, 2021
Dec. 24, 2022
Dec. 25, 2021
Income Statement [Abstract]        
Net sales $ 590,582 $ 548,349 $ 1,524,795 $ 1,291,488
Cost of sales 293,877 258,827 754,170 626,576
Gross profit 296,705 289,522 770,625 664,912
Operating expenses        
Research and development 118,063 107,101 343,250 294,913
Selling, general and administrative 37,262 38,247 115,502 111,526
Total operating expenses 155,325 145,348 458,752 406,439
Income from operations 141,380 144,174 311,873 258,473
Interest income 2,995 140 5,047 1,448
Interest expense (218) (218) (680) (730)
Other income (expense) (3,716) (87) (2,915) 1,530
Income before income taxes 140,441 144,009 313,325 260,721
Provision for income taxes 36,964 16,373 82,953 30,780
Net income $ 103,477 $ 127,636 $ 230,372 $ 229,941
Basic earnings per share (in dollars per share) $ 1.87 $ 2.23 $ 4.13 $ 4.01
Diluted earnings per share (in dollars per share) $ 1.83 $ 2.16 $ 4.02 $ 3.88
Basic weighted average common shares outstanding (in shares) 55,239 57,178 55,748 57,374
Diluted weighted average common shares outstanding (in shares) 56,583 59,031 57,280 59,317
v3.22.4
Consolidated Condensed Statements Of Comprehensive Income - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Dec. 24, 2022
Dec. 25, 2021
Dec. 24, 2022
Dec. 25, 2021
Statement of Comprehensive Income [Abstract]        
Net income $ 103,477 $ 127,636 $ 230,372 $ 229,941
Other comprehensive income (loss), before tax        
Foreign currency translation gain (loss) 468 (107) (1,235) (324)
Unrealized gain (loss) on marketable securities 533 (650) (407) (3,756)
Benefit (provision) for income taxes (112) 137 86 790
Comprehensive income $ 104,366 $ 127,016 $ 228,816 $ 226,651
v3.22.4
Consolidated Condensed Statements Of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Dec. 24, 2022
Dec. 25, 2021
Cash flows from operating activities:    
Net income $ 230,372 $ 229,941
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 52,358 45,156
Stock-based compensation expense 59,108 49,368
Deferred income taxes 6,430 (8,243)
Loss on retirement or write-off of long-lived assets 306 527
Other non-cash adjustments 3,017 282
Net change in operating assets and liabilities:    
Accounts receivable, net (30,229) (210,694)
Inventories (13,990) 32,413
Prepaid wafers 0 (195,000)
Other assets 4,516 (101,160)
Accounts payable and other accrued liabilities (26,619) (12,720)
Income taxes payable (3,455) 159
Acquisition-related liabilities 9,488 36,493
Net cash provided by (used in) operating activities 291,302 (133,478)
Cash flows from investing activities:    
Maturities and sales of available-for-sale marketable securities 10,346 366,582
Purchases of available-for-sale marketable securities (9,469) (77,716)
Purchases of property, equipment and software (23,764) (18,091)
Investments in technology (1,315) (3,463)
Acquisition of business, net of cash obtained 0 (276,884)
Net cash used in investing activities (24,202) (9,572)
Cash flows from financing activities:    
Debt issuance costs 0 (1,718)
Payment of acquisition-related holdback (30,949) 0
Issuance of common stock, net of shares withheld for taxes 1,524 8,562
Repurchase of stock to satisfy employee tax withholding obligations (16,563) (18,335)
Repurchase and retirement of common stock (156,382) (92,502)
Net cash used in financing activities (202,370) (103,993)
Net increase (decrease) in cash and cash equivalents 64,730 (247,043)
Cash and cash equivalents at beginning of period 369,814 442,164
Cash and cash equivalents at end of period $ 434,544 $ 195,121
v3.22.4
Consolidated Condensed Statements Of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Earnings (Deficit)
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Mar. 27, 2021   57,652      
Beginning balance at Mar. 27, 2021 $ 1,389,005 $ 58 $ 1,498,761 $ (112,689) $ 2,875
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 229,941     229,941  
Change in unrealized gain (loss) on marketable securities, net of tax (2,966)       (2,966)
Change in foreign currency translation adjustments (324)       (324)
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes (in shares)   766      
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes (9,775) $ 1 8,560 (18,336)  
Repurchase and retirement of common stock (in shares)   (1,172)      
Repurchase and retirement of common stock (92,502) $ (2)   (92,500)  
Stock-based compensation 49,368   49,368    
Ending balance (in shares) at Dec. 25, 2021   57,246      
Ending balance at Dec. 25, 2021 1,562,747 $ 57 1,556,689 6,416 (415)
Beginning balance (in shares) at Sep. 25, 2021   57,128      
Beginning balance at Sep. 25, 2021 1,468,090 $ 57 1,533,500 (65,672) 205
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 127,636     127,636  
Change in unrealized gain (loss) on marketable securities, net of tax (513)       (513)
Change in foreign currency translation adjustments (107)       (107)
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes (in shares)   619      
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes (10,193) $ 1 5,357 (15,551)  
Repurchase and retirement of common stock (in shares)   (501)      
Repurchase and retirement of common stock (39,998) $ (1)   (39,997)  
Stock-based compensation 17,832   17,832    
Ending balance (in shares) at Dec. 25, 2021   57,246      
Ending balance at Dec. 25, 2021 1,562,747 $ 57 1,556,689 6,416 (415)
Beginning balance (in shares) at Mar. 26, 2022   56,596      
Beginning balance at Mar. 26, 2022 1,599,817 $ 57 1,578,370 23,435 (2,045)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 230,372     230,372  
Change in unrealized gain (loss) on marketable securities, net of tax (321)       (321)
Change in foreign currency translation adjustments (1,235)       (1,235)
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes (in shares)   637      
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes (15,039) $ 1 1,523 (16,563)  
Repurchase and retirement of common stock (in shares)   (2,021)      
Repurchase and retirement of common stock (156,382) $ (3)   (156,379)  
Stock-based compensation 59,108   59,108    
Ending balance (in shares) at Dec. 24, 2022   55,212      
Ending balance at Dec. 24, 2022 1,716,320 $ 55 1,639,001 80,865 (3,601)
Beginning balance (in shares) at Sep. 24, 2022   55,426      
Beginning balance at Sep. 24, 2022 1,654,614 $ 55 1,618,122 40,927 (4,490)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 103,477     103,477  
Change in unrealized gain (loss) on marketable securities, net of tax 421       421
Change in foreign currency translation adjustments 468       468
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes (in shares)   499      
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes (13,148) $ 1 392 (13,541)  
Repurchase and retirement of common stock (in shares)   (713)      
Repurchase and retirement of common stock (49,999) $ (1)   (49,998)  
Stock-based compensation 20,487   20,487    
Ending balance (in shares) at Dec. 24, 2022   55,212      
Ending balance at Dec. 24, 2022 $ 1,716,320 $ 55 $ 1,639,001 $ 80,865 $ (3,601)
v3.22.4
Basis of Presentation
 9 Months Ended
Dec. 24, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation Basis of PresentationThe unaudited consolidated condensed financial statements have been prepared by Cirrus Logic, Inc. (“Cirrus Logic,” “we,” “us,” “our,” or the “Company”) pursuant to the rules and regulations of the Securities and Exchange Commission (the “Commission”).  The accompanying unaudited consolidated condensed financial statements do not include complete footnotes and financial presentations.  As a result, these financial statements should be read along with the audited consolidated financial statements and notes thereto for the year ended March 26, 2022, included in our Annual Report on Form 10-K filed with the Commission on May 20, 2022.  In our opinion, the financial statements reflect all material adjustments, including normal recurring adjustments, necessary for a fair presentation of the financial position, operating results and cash flows for those periods presented.  The preparation of financial statements in conformity with United States (“U.S.”) generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect reported assets, liabilities, revenues and expenses.  Actual results could differ from those estimates and assumptions.  Moreover, the results of operations for the interim periods presented are not necessarily indicative of the results that may be expected for the entire year.
v3.22.4
Recently Issued Accounting Pronouncements
 9 Months Ended
Dec. 24, 2022
Accounting Policies [Abstract]  
Recently Issued Accounting Pronouncements Recently Issued Accounting Pronouncements
In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805) – Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured at the acquisition date in accordance with Revenue from Contracts with Customers (Topic 606) as if the acquirer had originated the contracts. Prior to the issuance of this ASU, contract assets and liabilities were recognized at fair value on the acquisition date. This ASU is effective for fiscal years beginning after December 15, 2022, including interim periods within that fiscal year, with early adoption permitted, and should be applied on a prospective basis. The Company is currently evaluating the impact of this guidance, but does not expect a material impact to the financial statements upon adoption.

In November 2021, the FASB issued ASU No. 2021-10, Government Assistance (Topic 832) – Disclosures by Business Entities about Government Assistance, which requires annual disclosures about transactions with a government that are accounted for by applying a grant or contribution type accounting model. The disclosures would require information about the nature and related policy used for the transactions, the line items on the balance sheet and income statement that are affected and the amounts applicable to each financial statement line item, and significant terms and conditions of the transactions. This ASU is effective for financial statements issued for annual periods beginning after December 15, 2021, with early adoption permitted, and can be applied on a prospective or retrospective basis. The Company is currently evaluating the impact of this guidance, but does not expect a material impact to the financial statements upon adoption.
v3.22.4
Marketable Securities
 9 Months Ended
Dec. 24, 2022
Marketable Securities [Abstract]  
Marketable Securities Marketable Securities
The Company’s investments have been classified as available-for-sale securities in accordance with U.S. GAAP.  Marketable securities are categorized on the consolidated condensed balance sheet as "Marketable securities", within the short-term or long-term classification, as appropriate.

The following table is a summary of available-for-sale securities at December 24, 2022 (in thousands):
As of December 24, 2022Amortized
Cost		Gross
Unrealized
Gains		Gross
Unrealized
Losses		Estimated
Fair Value
(Net Carrying
Amount)
Corporate debt securities$70,044 $22 $(2,496)$67,570 
Non-U.S. government securities510 — (8)502 
U.S. Treasury securities4,944 — (220)4,724 
Agency discount notes384 — (23)361 
Total securities$75,882 $22 $(2,747)$73,157 

The Company typically invests in highly-rated securities with original maturities generally ranging from one to three years. The Company's specifically identified gross unrealized losses of $2.7 million related to securities with total amortized costs of approximately $72.4 million at December 24, 2022. Securities in a continuous unrealized loss position for more than
12 months as of December 24, 2022 had an aggregate amortized cost of $56.2 million and an aggregate unrealized loss of $2.3 million. The Company may sell certain of its marketable securities prior to their stated maturities for strategic reasons including, but not limited to, anticipated or actual changes in credit rating and duration management.  The Company records an allowance for credit loss when a decline in investment market value is due to credit-related factors. When evaluating an investment for impairment, the Company reviews factors including the length of time and extent to which fair value has been below cost basis, the financial condition of the issuer, changes in market interest rates and whether it is more likely than not the Company will be required to sell the investment before recovery of the investment’s cost basis. As of December 24, 2022, the Company does not consider any of its investments to be impaired.

The following table is a summary of available-for-sale securities at March 26, 2022 (in thousands):
As of March 26, 2022Amortized
Cost		Gross
Unrealized
Gains		Gross
Unrealized
Losses		Estimated
Fair Value
(Net Carrying
Amount)
Corporate debt securities$70,296 $2 $(2,133)$68,165 
Non-U.S. government securities509 — (9)500 
U.S. Treasury securities5,483 — (169)5,314 
Agency discount notes385 — (14)371 
Total securities$76,673 $2 $(2,325)$74,350 

The Company's specifically identified gross unrealized losses of $2.3 million related to securities with total amortized costs of approximately $75.5 million at March 26, 2022. Securities in a continuous unrealized loss position for more than 12 months as of March 26, 2022 had an aggregate amortized cost of $3.5 million and an aggregate unrealized loss of $0.1 million. As of March 26, 2022, the Company did not consider any of its investments to be impaired.

The cost and estimated fair value of available-for-sale securities by contractual maturities were as follows (in thousands):
December 24, 2022March 26, 2022
AmortizedEstimatedAmortizedEstimated
CostFair ValueCostFair Value
Within 1 year$28,966 $28,373 $10,697 $10,601 
After 1 year46,916 44,784 65,976 63,749 
Total$75,882 $73,157 $76,673 $74,350 
v3.22.4
Fair Value of Financial Instruments
 9 Months Ended
Dec. 24, 2022
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments Fair Value of Financial Instruments
The Company has determined that the only material assets and liabilities in the Company’s financial statements that are required to be measured at fair value on a recurring basis are the Company’s cash equivalents and marketable securities portfolio.  The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement.  The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

•Level 1 - Quoted prices in active markets for identical assets or liabilities.
•Level 2 - Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
•Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The Company’s cash equivalents and marketable securities portfolio consist of money market funds, commercial paper, debt securities, non-U.S. government securities, U.S Treasury securities and securities of U.S. government-sponsored enterprises and are reflected on our consolidated condensed balance sheets under the headings cash and cash equivalents,
marketable securities, and long-term marketable securities.  The Company determines the fair value of its marketable securities portfolio by obtaining non-binding market prices from third-party pricing providers on the last day of the quarter, whose sources may use quoted prices in active markets for identical assets (Level 1 inputs) or inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs) in determining fair value.

The Company's long-term revolving credit facility, described in Note 8, bears interest at a base rate plus applicable margin or LIBOR plus applicable margin. As of December 24, 2022, there are no amounts drawn under the credit facility and the fair value is zero.

As of December 24, 2022 and March 26, 2022, the Company has no material Level 3 assets or liabilities.  There were no transfers between Level 1, Level 2, or Level 3 measurements for the three or nine months ended December 24, 2022. 

The following summarizes the fair value of our financial instruments at December 24, 2022 (in thousands):
Quoted Prices
in Active
Markets for
Identical
Assets
Level 1		Significant
Other
Observable
Inputs
Level 2		Significant
Unobservable
Inputs
Level 3		Total
Assets:    
Cash equivalents    
Money market funds$393,626 $— $— $393,626 
Available-for-sale securities    
Corporate debt securities$— $67,570 $— $67,570 
Non-U.S. government securities— 502 — 502 
U.S. Treasury securities4,724 — — 4,724 
Agency discount notes— 361 — 361 
$4,724 $68,433 $— $73,157 

The following summarizes the fair value of our financial instruments at March 26, 2022 (in thousands):
Quoted Prices
in Active
Markets for
Identical
Assets
Level 1		Significant
Other
Observable
Inputs
Level 2		Significant
Unobservable
Inputs
Level 3		Total
Assets:
Cash equivalents    
Money market funds$217,151 $— $— $217,151 
Commercial paper— 249 — 249 
$217,151 $249 $— $217,400 
Available-for-sale securities    
Corporate debt securities$— $68,165 $— $68,165 
Non-U.S. government securities— 500 — 500 
U.S. Treasury securities5,314 — — 5,314 
Agency discount notes— 371 — 371 
$5,314 $69,036 $— $74,350 
v3.22.4
Derivative Financial Instruments
 9 Months Ended
Dec. 24, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments Derivative Financial Instruments
Foreign Currency Forward Contracts

The Company uses foreign currency forward contracts to reduce the earnings impact that exchange rate fluctuations have on non-functional currency balance sheet exposures. The Company recognizes both the gains and losses on foreign currency forward contracts and the gains and losses on the remeasurement of non-functional currency assets and liabilities within "Other income (expense)" in the consolidated condensed statements of income. The Company does not apply hedge accounting to these foreign currency derivative instruments.

As of December 24, 2022, the Company held one foreign currency forward contract denominated in British Pound Sterling with a notional value of $1.1 million. The fair value of this contract was not material as of December 24, 2022.

The before-tax effect of derivative instruments not designated as hedging instruments was as follows (in thousands):
Three Months EndedNine Months Ended
December 24,December 25,December 24,December 25,
2022202120222021Location
Gain (loss) recognized in income:
Foreign currency forward contracts$348 $(285)$(447)$(350)Other income (expense)
v3.22.4
Accounts Receivable, net
 9 Months Ended
Dec. 24, 2022
Accounts Receivable, after Allowance for Credit Loss [Abstract]  
Accounts Receivable, net Accounts Receivable, netThe following are the components of accounts receivable, net (in thousands):
December 24,March 26,
20222022
Gross accounts receivable$270,493 $240,264 
Allowance for doubtful accounts— — 
Accounts receivable, net$270,493 $240,264 
v3.22.4
Inventories
 9 Months Ended
Dec. 24, 2022
Inventory Disclosure [Abstract]  
Inventories InventoriesInventories are comprised of the following (in thousands):
December 24,March 26,
20222022
Work in process$112,206 $95,188 
Finished goods40,220 43,248 
$152,426 $138,436 
v3.22.4
Revolving Credit Facility
 9 Months Ended
Dec. 24, 2022
Line of Credit Facility [Abstract]  
Revolving Credit Facility Revolving Credit Facility
On July 8, 2021, the Company entered into a second amended and restated credit agreement (the “Second Amended Credit Agreement”) with Wells Fargo Bank, National Association, as administrative agent, and the lenders party thereto. The Second Amended Credit Agreement provides for a $300 million senior secured revolving credit facility (the “Revolving Credit Facility”). The Revolving Credit Facility matures on July 8, 2026 (the “Maturity Date”). The Revolving Credit Facility is required to be guaranteed by all of Cirrus Logic’s material domestic subsidiaries (the "Subsidiary Guarantors"). The Revolving Credit Facility is secured by substantially all the assets of Cirrus Logic and any Subsidiary Guarantors, except for certain excluded assets.

Borrowings under the Revolving Credit Facility may, at Cirrus Logic’s election, bear interest at either (a) a base rate plus the applicable margin ("Base Rate Loans") or (b) a LIBOR rate plus the applicable margin ("LIBOR Rate Loans"). The applicable margin ranges from 0% to 0.75% per annum for Base Rate Loans and 1.00% to 1.75% per annum for LIBOR Rate Loans based on the ratio of consolidated funded indebtedness to consolidated EBITDA for the most recently ended period of
four consecutive fiscal quarters (the “Consolidated Leverage Ratio”). The Second Amended Credit Agreement further provides a method for determining an alternative rate of interest if the LIBOR Rate is no longer available or upon the occurrence of certain other events. A Commitment Fee accrues at a rate per annum ranging from 0.175% to 0.275% (based on the Consolidated Leverage Ratio) on the average daily unused portion of the commitment of the lenders.

The Second Amended Credit Agreement contains customary affirmative covenants, including, among others, covenants regarding the payment of taxes and other obligations, maintenance of insurance, reporting requirements, and compliance with applicable laws and regulations. Further, the Second Amended Credit Agreement contains customary negative covenants limiting the ability of Cirrus Logic or any Subsidiary to, among other things, incur debt, grant liens, make investments, effect certain fundamental changes, make certain asset dispositions, and make certain restricted payments. The Revolving Credit Facility also contains certain financial covenants providing that (a) the ratio of consolidated funded indebtedness (minus up to $200 million of unrestricted cash and cash equivalents available on such date) to consolidated EBITDA for the prior four consecutive quarters must not be greater than 3.00 to 1.00 (the “Consolidated Net Leverage Ratio”) and (b) the ratio of consolidated EBITDA for the prior four consecutive quarters to consolidated interest expense paid or payable in cash for the prior four consecutive quarters must not be less than 3.00 to 1.00 (the “Consolidated Interest Coverage Ratio”).
As of December 24, 2022, the Company had no amounts outstanding under the Revolving Credit Facility and was in compliance with all covenants under the Second Amended Credit Agreement.
v3.22.4
Revenues
 9 Months Ended
Dec. 24, 2022
Revenue from Contract with Customer [Abstract]  
Revenues Revenues
Disaggregation of revenue

We disaggregate revenue from contracts with customers by product line and ship to location of the customer. Sales are designated in the respective product line categories of Audio and High-Performance Mixed-Signal.

Total net sales based on the product line disaggregation criteria described above are shown in the table below (in thousands).
Three Months EndedNine Months Ended
December 24,December 25,December 24,December 25,
2022202120222021
Audio Products$347,297 $341,897 $939,604 $860,027 
High-Performance Mixed-Signal Products243,285 206,452 585,191 431,461 
$590,582 $548,349 $1,524,795 $1,291,488 

The geographic regions that are reviewed are China, the United States, and the rest of the world. Total net sales based on the geographic disaggregation criteria described are as follows (in thousands):
Three Months EndedNine Months Ended
December 24,December 25,December 24,December 25,
2022202120222021
China$397,222 $384,254 $1,008,967 $855,772 
United States22,140 10,341 42,439 21,697 
Rest of World171,220 153,754 473,389 414,019 
$590,582 $548,349 $1,524,795 $1,291,488 
Performance obligations

The Company's single performance obligation is the delivery of promised goods to the customer. The promised goods are explicitly stated in the customer contract and are comprised of either a single type of good or a series of goods that are substantially the same, have the same pattern of transfer to the customer, and are neither capable of being distinct nor separable from the other promised goods in the contract. This performance obligation is satisfied upon transfer of control of the promised goods to the customer, as defined per the shipping terms within the customer's contract. The vast majority of the Company's contracts with customers have an original expected term length of one year or less. As allowed by Accounting Standards
Codification ("ASC") 606, Revenue from Contracts with Customers, the Company has not disclosed the value of any unsatisfied performance obligations related to these contracts.

The Company’s products typically include a warranty period of one to three years. These warranties qualify as assurance-type warranties, as goods can be returned for product non-conformance and defect only. As such, these warranties are accounted for under ASC 460, Guarantees, and are not considered a separate performance obligation.

Contract balances

Payments are typically due within 30 to 60 days of invoicing and terms do not include significant financing components or noncash consideration. There have been no material impairment losses on accounts receivable. There are no material contract assets or contract liabilities recorded on the consolidated condensed balance sheets.

Transaction price

The transaction price is the amount of consideration to which the Company expects to be entitled in exchange for transferring the promised goods to the customer. Fixed pricing is the consideration that is agreed upon in the customer contract. Variable pricing includes rights of return, price protection and stock rotation. Rights of return costs are estimated using the "most likely amount" method by reviewing historical returns to determine the most likely customer return rate and applying materiality thresholds. Price protection includes price adjustments available to certain distributors based upon established book price and a stated adjustment period. Stock rotation is also available to certain distributors based on a stated maximum of prior billings.

The Company estimates all variable consideration at the most likely amount that it expects to be entitled to receive. The estimate is based on current and historical information, including recent sales activity and pricing, available to the Company. Variable consideration is only included in the transaction price to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The Company defers all variable consideration that does not meet the revenue recognition criteria.
v3.22.4
Income Taxes
 9 Months Ended
Dec. 24, 2022
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
Our provision for income taxes is based on estimated effective tax rates derived from an estimate of annual consolidated earnings before taxes, adjusted for nondeductible expenses, other permanent items, and any applicable income tax credits.

The following table presents the provision for income taxes (in thousands) and the effective tax rates:
Three Months EndedNine Months Ended
December 24,December 25,December 24,December 25,
2022202120222021
Income before income taxes$140,441 $144,009 $313,325 $260,721 
Provision for income taxes$36,964 $16,373 $82,953 $30,780 
Effective tax rate26.3 %11.4 %26.5 %11.8 %

Our income tax expense was $37.0 million and $16.4 million for the third quarters of fiscal years 2023 and 2022, respectively, resulting in effective tax rates of 26.3 percent and 11.4 percent, respectively.  Our income tax expense was $83.0 million and $30.8 million for the first nine months of fiscal years 2023 and 2022, respectively, resulting in effective tax rates of 26.5 percent and 11.8 percent, respectively. Our effective tax rates for the third quarter and first nine months of fiscal year 2023 increased significantly year over year and were higher than the federal statutory rate primarily due to a provision in the Tax Cuts and Jobs Act of 2017 whereby research and development expenditures incurred in tax years beginning after December 31, 2021 must be capitalized and amortized ratably over five or fifteen years for tax purposes, depending on the location in which the research activities are conducted. The resulting capitalization of research and development costs impacts the calculation of the Company's global intangible low-taxed income, which is treated as a period cost, beginning in the first quarter of fiscal year 2023. Our effective tax rates for the third quarter and first nine months of fiscal year 2022 were lower than the federal statutory rate primarily due to the effect of income earned in certain foreign jurisdictions that is taxed below the federal statutory rate and excess tax benefits from stock-based compensation.

The Company records unrecognized tax benefits for the estimated risk associated with tax positions taken on tax returns.  At December 24, 2022, the Company had unrecognized tax benefits of $32.9 million, all of which would impact the
effective tax rate if recognized.  The Company’s total unrecognized tax benefits are classified as “Non-current income taxes" in the consolidated condensed balance sheets. The Company recognizes interest and penalties related to unrecognized tax benefits in the provision for income taxes.  As of December 24, 2022, the balance of accrued interest and penalties, net of tax, was $6.2 million. 

On July 27, 2015, the U.S. Tax Court issued an opinion in Altera Corp. et al. v. Commissioner which concluded that the regulations relating to the treatment of stock-based compensation expense in intercompany cost-sharing arrangements were invalid. In 2016 the U.S. Internal Revenue Service appealed the decision to the U.S. Court of Appeals for the Ninth Circuit (the “Ninth Circuit”). On July 24, 2018, the Ninth Circuit issued a decision that was subsequently withdrawn and a reconstituted panel conferred on the appeal. On June 7, 2019, the Ninth Circuit reversed the decision of the U.S. Tax Court and upheld the cost-sharing regulations. On February 10, 2020, Altera Corp. filed a Petition for a Writ of Certiorari with the Supreme Court of the United States, which was denied by the Supreme Court on June 22, 2020. Although the issue is now resolved in the Ninth Circuit, the Ninth Circuit's opinion is not binding in other circuits. The potential impact of this issue on the Company, which is not located within the jurisdiction of the Ninth Circuit, is unclear at this time. We will continue to monitor developments related to this issue and the potential impact of those developments on the Company's current and prior fiscal years.

The Company and its subsidiaries are subject to U.S. federal income tax as well as income tax in multiple state and foreign jurisdictions. Fiscal years 2017 through 2022 remain open to examination by the major taxing jurisdictions to which the Company is subject, although carry forward attributes that were generated in tax years prior to fiscal year 2017 may be adjusted upon examination by the tax authorities if they have been, or will be, used in a future period. 

The Company's fiscal year 2017, 2018, and 2019 federal income tax returns are under examination by the U.S. Internal Revenue Service ("IRS").  The IRS has proposed adjustments that would increase U.S. taxable income related to transfer pricing matters with respect to our U.S. and U.K. affiliated companies, and in the first quarter of fiscal year 2023 issued a Revenue Agent’s Report asserting additional tax of approximately $170.5 million, excluding interest, and imposing penalties of approximately $63.7 million. We do not agree with the IRS's positions and we intend to vigorously dispute the proposed adjustments. We intend to pursue resolution through the administrative process with the IRS Independent Office of Appeals and, if necessary, through judicial remedies. We expect it could take a number of years to reach resolution on these matters. Although the final resolution of these matters is uncertain, the Company believes adequate amounts have been reserved for any adjustments to the provision for income taxes that may ultimately result. However, if the IRS prevails in these matters, the amount of assessed tax, interest, and penalties, if any, could be material and may have an adverse impact on our financial position, results of operations, and cash flows in future periods. The Company is not under an income tax audit in any other major taxing jurisdiction.
v3.22.4
Net Income Per Share
 9 Months Ended
Dec. 24, 2022
Earnings Per Share [Abstract]  
Net Income Per Share Net Income Per ShareBasic net income per share is based on the weighted effect of common shares issued and outstanding and is calculated by dividing net income by the basic weighted average shares outstanding during the period.  Diluted net income per share is calculated by dividing net income by the weighted average number of common shares used in the basic net income per share calculation, plus the equivalent number of common shares that would be issued assuming exercise or conversion of all potentially dilutive common shares outstanding.  These potentially dilutive items consist primarily of outstanding stock options and restricted stock grants.
The following table details the calculation of basic and diluted earnings per share for the three and nine months ended December 24, 2022 and December 25, 2021 (in thousands, except per share amounts):
Three Months EndedNine Months Ended
December 24,December 25,December 24,December 25,
2022202120222021
Numerator:    
Net income$103,477 $127,636 $230,372 $229,941 
Denominator:    
Weighted average shares outstanding55,239 57,178 55,748 57,374 
Effect of dilutive securities1,344 1,853 1,532 1,943 
Weighted average diluted shares56,583 59,031 57,280 59,317 
Basic earnings per share$1.87 $2.23 $4.13 $4.01 
Diluted earnings per share$1.83 $2.16 $4.02 $3.88 
The weighted outstanding shares excluded from our diluted calculation for the three and nine months ended December 24, 2022 were 273 thousand and 253 thousand, respectively, as the shares were anti-dilutive. The weighted outstanding shares excluded from our diluted calculation for the three and nine months ended December 25, 2021 were 102 thousand and 97 thousand, respectively, as the shares were anti-dilutive.
v3.22.4
Commitment and Contingencies
 9 Months Ended
Dec. 24, 2022
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Capacity Reservation Agreement

On July 28, 2021, the Company entered into a Capacity Reservation and Wafer Supply Commitment Agreement (the “Capacity Reservation Agreement”) with GLOBALFOUNDRIES Singapore Pte. Ltd. (“GlobalFoundries”) to provide the Company a wafer capacity commitment and wafer pricing for Company products for calendar years 2022-2026 (the “Commitment Period”).
The Capacity Reservation Agreement requires GlobalFoundries to provide, and the Company to purchase, a defined number of wafers on a quarterly basis for the Commitment Period, subject to shortfall payments. In exchange for GlobalFoundries’ capacity commitment, the Company paid a $60 million non-refundable capacity reservation fee, which is amortized over the Commitment Period. The amortized portion of this reservation fee is recorded in "Other current assets" and "Other assets" on the consolidated condensed balance sheets within the short-term or long-term classification, as appropriate. In addition, the Company pre-paid GlobalFoundries $195 million for future wafer purchases, which will be credited back to the Company as a portion of the price of wafers purchased beginning in the third quarter of calendar year 2023. This prepayment is currently recorded in "Long-term prepaid wafers" and "Other current assets" on the consolidated condensed balance sheets.
v3.22.4
Legal Matters
 9 Months Ended
Dec. 24, 2022
Commitments and Contingencies Disclosure [Abstract]  
Legal Matters Legal Matters
From time to time, we are involved in legal proceedings concerning matters arising in connection with the conduct of our business activities.  We regularly evaluate the status of legal proceedings in which we are involved in order to assess whether a loss is probable or there is a reasonable possibility that a loss or additional loss may have been incurred, and to determine if accruals are appropriate.  We further evaluate each legal proceeding to assess whether an estimate of possible loss or range of loss can be made.    

Based on current knowledge, management does not believe that there are any pending matters that could potentially have a material adverse effect on our business, financial condition, results of operations or cash flows.  However, we are engaged in various legal actions in the normal course of business.  There can be no assurances in light of the inherent uncertainties involved in any potential legal proceedings, some of which are beyond our control, and an adverse outcome in any legal proceeding could be material to our results of operations or cash flows for any particular reporting period.
v3.22.4
Stockholders' Equity
 9 Months Ended
Dec. 24, 2022
Stockholders' Equity Note [Abstract]  
Stockholders' Equity Stockholders' Equity
Common Stock 

The Company issued a net 0.5 million and 0.6 million shares of common stock during the three and nine months ended December 24, 2022, respectively, and a net 0.6 million and 0.8 million shares of common stock during the three and nine months ended December 25, 2021, respectively, pursuant to the Company's equity incentive plans.

Share Repurchase Program 
In January 2021, the Board of Directors authorized the repurchase of $350 million of the Company’s common stock. Since inception, approximately $313.9 million of the Company’s common stock has been repurchased under this share authorization, leaving approximately $36.1 million available for repurchase as of December 24, 2022.  During the three months ended December 24, 2022, the Company repurchased 0.7 million shares of its common stock under the 2021 authorization for $50.0 million, at an average cost of $70.14 per share. During the nine months ended December 24, 2022, the Company repurchased 2.0 million shares of its common stock under the 2021 authorization for $156.4 million, at an average cost of $77.39 per share. Additionally, in July 2022, the Company announced that the Board of Directors authorized the repurchase of up to an additional $500 million of the Company's common stock. No shares have been repurchased under the 2022 authorization as of December 24, 2022.
v3.22.4
Segment Information
 9 Months Ended
Dec. 24, 2022
Segment Reporting [Abstract]  
Segment Information Segment Information
We determine our operating segments in accordance with FASB guidelines.  Our Chief Executive Officer (“CEO”) has been identified as the chief operating decision maker under these guidelines. 

The Company operates and tracks its results in one reportable segment, but reports revenue in two product lines, Audio and High-Performance Mixed-Signal.  Our CEO receives and uses enterprise-wide financial information to assess financial performance and allocate resources, rather than detailed information at a product line level.  Additionally, our product lines have similar characteristics and customers.  They share support functions such as sales, public relations, supply chain management, various research and development and engineering support, in addition to the general and administrative functions of human resources, legal, finance and information technology.  Therefore, there is no complete, discrete financial information maintained for these product lines. Revenue by product line is disclosed in Note 9 - Revenues.
v3.22.4
Recently Issued Accounting Pronouncements (Policies)
 9 Months Ended
Dec. 24, 2022
Accounting Policies [Abstract]  
Recently Issued Accounting Pronouncements
In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805) – Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured at the acquisition date in accordance with Revenue from Contracts with Customers (Topic 606) as if the acquirer had originated the contracts. Prior to the issuance of this ASU, contract assets and liabilities were recognized at fair value on the acquisition date. This ASU is effective for fiscal years beginning after December 15, 2022, including interim periods within that fiscal year, with early adoption permitted, and should be applied on a prospective basis. The Company is currently evaluating the impact of this guidance, but does not expect a material impact to the financial statements upon adoption.

In November 2021, the FASB issued ASU No. 2021-10, Government Assistance (Topic 832) – Disclosures by Business Entities about Government Assistance, which requires annual disclosures about transactions with a government that are accounted for by applying a grant or contribution type accounting model. The disclosures would require information about the nature and related policy used for the transactions, the line items on the balance sheet and income statement that are affected and the amounts applicable to each financial statement line item, and significant terms and conditions of the transactions. This ASU is effective for financial statements issued for annual periods beginning after December 15, 2021, with early adoption permitted, and can be applied on a prospective or retrospective basis. The Company is currently evaluating the impact of this guidance, but does not expect a material impact to the financial statements upon adoption.
Marketable Securities The Company’s investments have been classified as available-for-sale securities in accordance with U.S. GAAP.  Marketable securities are categorized on the consolidated condensed balance sheet as "Marketable securities", within the short-term or long-term classification, as appropriate.
Fair Value of Financial Instruments
The Company has determined that the only material assets and liabilities in the Company’s financial statements that are required to be measured at fair value on a recurring basis are the Company’s cash equivalents and marketable securities portfolio.  The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement.  The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

•Level 1 - Quoted prices in active markets for identical assets or liabilities.
•Level 2 - Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
•Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The Company’s cash equivalents and marketable securities portfolio consist of money market funds, commercial paper, debt securities, non-U.S. government securities, U.S Treasury securities and securities of U.S. government-sponsored enterprises and are reflected on our consolidated condensed balance sheets under the headings cash and cash equivalents,
marketable securities, and long-term marketable securities.  The Company determines the fair value of its marketable securities portfolio by obtaining non-binding market prices from third-party pricing providers on the last day of the quarter, whose sources may use quoted prices in active markets for identical assets (Level 1 inputs) or inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs) in determining fair value.
Revenues
Disaggregation of revenue

We disaggregate revenue from contracts with customers by product line and ship to location of the customer. Sales are designated in the respective product line categories of Audio and High-Performance Mixed-Signal.
Performance obligations

The Company's single performance obligation is the delivery of promised goods to the customer. The promised goods are explicitly stated in the customer contract and are comprised of either a single type of good or a series of goods that are substantially the same, have the same pattern of transfer to the customer, and are neither capable of being distinct nor separable from the other promised goods in the contract. This performance obligation is satisfied upon transfer of control of the promised goods to the customer, as defined per the shipping terms within the customer's contract. The vast majority of the Company's contracts with customers have an original expected term length of one year or less. As allowed by Accounting Standards
Codification ("ASC") 606, Revenue from Contracts with Customers, the Company has not disclosed the value of any unsatisfied performance obligations related to these contracts.

The Company’s products typically include a warranty period of one to three years. These warranties qualify as assurance-type warranties, as goods can be returned for product non-conformance and defect only. As such, these warranties are accounted for under ASC 460, Guarantees, and are not considered a separate performance obligation.

Contract balances

Payments are typically due within 30 to 60 days of invoicing and terms do not include significant financing components or noncash consideration. There have been no material impairment losses on accounts receivable. There are no material contract assets or contract liabilities recorded on the consolidated condensed balance sheets.

Transaction price

The transaction price is the amount of consideration to which the Company expects to be entitled in exchange for transferring the promised goods to the customer. Fixed pricing is the consideration that is agreed upon in the customer contract. Variable pricing includes rights of return, price protection and stock rotation. Rights of return costs are estimated using the "most likely amount" method by reviewing historical returns to determine the most likely customer return rate and applying materiality thresholds. Price protection includes price adjustments available to certain distributors based upon established book price and a stated adjustment period. Stock rotation is also available to certain distributors based on a stated maximum of prior billings.

The Company estimates all variable consideration at the most likely amount that it expects to be entitled to receive. The estimate is based on current and historical information, including recent sales activity and pricing, available to the Company. Variable consideration is only included in the transaction price to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The Company defers all variable consideration that does not meet the revenue recognition criteria.
Segment Information
We determine our operating segments in accordance with FASB guidelines.  Our Chief Executive Officer (“CEO”) has been identified as the chief operating decision maker under these guidelines. 

The Company operates and tracks its results in one reportable segment, but reports revenue in two product lines, Audio and High-Performance Mixed-Signal.  Our CEO receives and uses enterprise-wide financial information to assess financial performance and allocate resources, rather than detailed information at a product line level.  Additionally, our product lines have similar characteristics and customers.  They share support functions such as sales, public relations, supply chain management, various research and development and engineering support, in addition to the general and administrative functions of human resources, legal, finance and information technology.  Therefore, there is no complete, discrete financial information maintained for these product lines. Revenue by product line is disclosed in Note 9 - Revenues.
v3.22.4
Marketable Securities (Tables)
 9 Months Ended
Dec. 24, 2022
Marketable Securities [Abstract]  
Schedule of Available-for-sale Securities The following table is a summary of available-for-sale securities at December 24, 2022 (in thousands):
As of December 24, 2022Amortized
Cost		Gross
Unrealized
Gains		Gross
Unrealized
Losses		Estimated
Fair Value
(Net Carrying
Amount)
Corporate debt securities$70,044 $22 $(2,496)$67,570 
Non-U.S. government securities510 — (8)502 
U.S. Treasury securities4,944 — (220)4,724 
Agency discount notes384 — (23)361 
Total securities$75,882 $22 $(2,747)$73,157 
The following table is a summary of available-for-sale securities at March 26, 2022 (in thousands):
As of March 26, 2022Amortized
Cost		Gross
Unrealized
Gains		Gross
Unrealized
Losses		Estimated
Fair Value
(Net Carrying
Amount)
Corporate debt securities$70,296 $2 $(2,133)$68,165 
Non-U.S. government securities509 — (9)500 
U.S. Treasury securities5,483 — (169)5,314 
Agency discount notes385 — (14)371 
Total securities$76,673 $2 $(2,325)$74,350 
Schedule of Cost and Estimated Fair Value of Available-for-sale Securities by Contractual Maturity
The cost and estimated fair value of available-for-sale securities by contractual maturities were as follows (in thousands):
December 24, 2022March 26, 2022
AmortizedEstimatedAmortizedEstimated
CostFair ValueCostFair Value
Within 1 year$28,966 $28,373 $10,697 $10,601 
After 1 year46,916 44,784 65,976 63,749 
Total$75,882 $73,157 $76,673 $74,350 
v3.22.4
Fair Value of Financial Instruments (Tables)
 9 Months Ended
Dec. 24, 2022
Fair Value Disclosures [Abstract]  
Schedule of Fair Value of Financial Assets and Liabilities
The following summarizes the fair value of our financial instruments at December 24, 2022 (in thousands):
Quoted Prices
in Active
Markets for
Identical
Assets
Level 1		Significant
Other
Observable
Inputs
Level 2		Significant
Unobservable
Inputs
Level 3		Total
Assets:    
Cash equivalents    
Money market funds$393,626 $— $— $393,626 
Available-for-sale securities    
Corporate debt securities$— $67,570 $— $67,570 
Non-U.S. government securities— 502 — 502 
U.S. Treasury securities4,724 — — 4,724 
Agency discount notes— 361 — 361 
$4,724 $68,433 $— $73,157 

The following summarizes the fair value of our financial instruments at March 26, 2022 (in thousands):
Quoted Prices
in Active
Markets for
Identical
Assets
Level 1		Significant
Other
Observable
Inputs
Level 2		Significant
Unobservable
Inputs
Level 3		Total
Assets:
Cash equivalents    
Money market funds$217,151 $— $— $217,151 
Commercial paper— 249 — 249 
$217,151 $249 $— $217,400 
Available-for-sale securities    
Corporate debt securities$— $68,165 $— $68,165 
Non-U.S. government securities— 500 — 500 
U.S. Treasury securities5,314 — — 5,314 
Agency discount notes— 371 — 371 
$5,314 $69,036 $— $74,350 
v3.22.4
Derivative Financial Instruments (Tables)
 9 Months Ended
Dec. 24, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Before-Tax Effect of Derivative Instruments Not Designated as Hedging Instruments
The before-tax effect of derivative instruments not designated as hedging instruments was as follows (in thousands):
Three Months EndedNine Months Ended
December 24,December 25,December 24,December 25,
2022202120222021Location
Gain (loss) recognized in income:
Foreign currency forward contracts$348 $(285)$(447)$(350)Other income (expense)
v3.22.4
Accounts Receivable, net (Tables)
 9 Months Ended
Dec. 24, 2022
Accounts Receivable, after Allowance for Credit Loss [Abstract]  
Components of Accounts Receivable, net The following are the components of accounts receivable, net (in thousands):
December 24,March 26,
20222022
Gross accounts receivable$270,493 $240,264 
Allowance for doubtful accounts— — 
Accounts receivable, net$270,493 $240,264 
v3.22.4
Inventories (Tables)
 9 Months Ended
Dec. 24, 2022
Inventory Disclosure [Abstract]  
Schedule of Inventories Inventories are comprised of the following (in thousands):
December 24,March 26,
20222022
Work in process$112,206 $95,188 
Finished goods40,220 43,248 
$152,426 $138,436 
v3.22.4
Revenues (Tables)
 9 Months Ended
Dec. 24, 2022
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue
Total net sales based on the product line disaggregation criteria described above are shown in the table below (in thousands).
Three Months EndedNine Months Ended
December 24,December 25,December 24,December 25,
2022202120222021
Audio Products$347,297 $341,897 $939,604 $860,027 
High-Performance Mixed-Signal Products243,285 206,452 585,191 431,461 
$590,582 $548,349 $1,524,795 $1,291,488 

The geographic regions that are reviewed are China, the United States, and the rest of the world. Total net sales based on the geographic disaggregation criteria described are as follows (in thousands):
Three Months EndedNine Months Ended
December 24,December 25,December 24,December 25,
2022202120222021
China$397,222 $384,254 $1,008,967 $855,772 
United States22,140 10,341 42,439 21,697 
Rest of World171,220 153,754 473,389 414,019 
$590,582 $548,349 $1,524,795 $1,291,488 
v3.22.4
Income Taxes (Tables)
 9 Months Ended
Dec. 24, 2022
Income Tax Disclosure [Abstract]  
Schedule of Provision for Income Taxes and Effective Tax Rates The following table presents the provision for income taxes (in thousands) and the effective tax rates:
Three Months EndedNine Months Ended
December 24,December 25,December 24,December 25,
2022202120222021
Income before income taxes$140,441 $144,009 $313,325 $260,721 
Provision for income taxes$36,964 $16,373 $82,953 $30,780 
Effective tax rate26.3 %11.4 %26.5 %11.8 %
v3.22.4
Net Income Per Share (Tables)
 9 Months Ended
Dec. 24, 2022
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following table details the calculation of basic and diluted earnings per share for the three and nine months ended December 24, 2022 and December 25, 2021 (in thousands, except per share amounts):
Three Months EndedNine Months Ended
December 24,December 25,December 24,December 25,
2022202120222021
Numerator:    
Net income$103,477 $127,636 $230,372 $229,941 
Denominator:    
Weighted average shares outstanding55,239 57,178 55,748 57,374 
Effect of dilutive securities1,344 1,853 1,532 1,943 
Weighted average diluted shares56,583 59,031 57,280 59,317 
Basic earnings per share$1.87 $2.23 $4.13 $4.01 
Diluted earnings per share$1.83 $2.16 $4.02 $3.88 
v3.22.4
Marketable Securities (Schedule of Available-for-sale Securities) (Details) - USD ($)
$ in Thousands
Dec. 24, 2022
Mar. 26, 2022
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost $ 75,882 $ 76,673
Gross Unrealized Gains 22 2
Gross Unrealized Losses (2,747) (2,325)
Estimated Fair Value (Net Carrying Amount) 73,157 74,350
Corporate debt securities    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 70,044 70,296
Gross Unrealized Gains 22 2
Gross Unrealized Losses (2,496) (2,133)
Estimated Fair Value (Net Carrying Amount) 67,570 68,165
Non-U.S. government securities    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 510 509
Gross Unrealized Gains 0 0
Gross Unrealized Losses (8) (9)
Estimated Fair Value (Net Carrying Amount) 502 500
U.S. Treasury securities    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 4,944 5,483
Gross Unrealized Gains 0 0
Gross Unrealized Losses (220) (169)
Estimated Fair Value (Net Carrying Amount) 4,724 5,314
Agency discount notes    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 384 385
Gross Unrealized Gains 0 0
Gross Unrealized Losses (23) (14)
Estimated Fair Value (Net Carrying Amount) $ 361 $ 371
v3.22.4
Marketable Securities (Narrative) (Details) - USD ($)
$ in Thousands
 9 Months Ended
Dec. 24, 2022
Mar. 26, 2022
Debt Securities, Available-for-sale [Line Items]    
Gross unrealized losses $ 2,747 $ 2,325
Amortized cost on available for sale securities held at gross unrealized loss 72,400 75,500
Securities in a continuous unrealized loss position for more than 12 months, amortized cost 56,200 3,500
Securities in a continuous unrealized loss position for more than 12 months, aggregate unrealized loss $ 2,300 $ 100
Minimum    
Debt Securities, Available-for-sale [Line Items]    
Maturity period for highly-rated securities 1 year  
Maximum    
Debt Securities, Available-for-sale [Line Items]    
Maturity period for highly-rated securities 3 years  
v3.22.4
Marketable Securities (Schedule of Cost and Estimated Fair Value of Available-for-sale Securities by Contractual Maturity) (Details) - USD ($)
$ in Thousands
Dec. 24, 2022
Mar. 26, 2022
Amortized Cost    
Within 1 year $ 28,966 $ 10,697
After 1 year 46,916 65,976
Amortized Cost 75,882 76,673
Estimated Fair Value    
Within 1 year 28,373 10,601
After 1 year 44,784 63,749
Estimated Fair Value (Net Carrying Amount) $ 73,157 $ 74,350
v3.22.4
Fair Value of Financial Instruments (Narrative) (Details)
Dec. 24, 2022
USD ($)
Fair Value Disclosures [Abstract]  
Amounts drawn under the credit facility $ 0
Credit facility, fair value $ 0
v3.22.4
Fair Value of Financial Instruments (Schedule of Fair Value of Financial Assets and Liabilities) (Details) - USD ($)
$ in Thousands
Dec. 24, 2022
Mar. 26, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents   $ 217,400
Available-for-sale securities $ 73,157 74,350
Quoted Prices in Active Markets for Identical Assets Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents   217,151
Available-for-sale securities 4,724 5,314
Significant Other Observable Inputs Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents   249
Available-for-sale securities 68,433 69,036
Significant Unobservable Inputs Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents   0
Available-for-sale securities 0 0
Corporate debt securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 67,570 68,165
Corporate debt securities | Quoted Prices in Active Markets for Identical Assets Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0 0
Corporate debt securities | Significant Other Observable Inputs Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 67,570 68,165
Corporate debt securities | Significant Unobservable Inputs Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0 0
Non-U.S. government securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 502 500
Non-U.S. government securities | Quoted Prices in Active Markets for Identical Assets Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0 0
Non-U.S. government securities | Significant Other Observable Inputs Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 502 500
Non-U.S. government securities | Significant Unobservable Inputs Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0 0
U.S. Treasury securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 4,724 5,314
U.S. Treasury securities | Quoted Prices in Active Markets for Identical Assets Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 4,724 5,314
U.S. Treasury securities | Significant Other Observable Inputs Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0 0
U.S. Treasury securities | Significant Unobservable Inputs Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0 0
Agency discount notes    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 361 371
Agency discount notes | Quoted Prices in Active Markets for Identical Assets Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0 0
Agency discount notes | Significant Other Observable Inputs Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 361 371
Agency discount notes | Significant Unobservable Inputs Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0 0
Money market funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents 393,626 217,151
Money market funds | Quoted Prices in Active Markets for Identical Assets Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents 393,626 217,151
Money market funds | Significant Other Observable Inputs Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents 0 0
Money market funds | Significant Unobservable Inputs Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents $ 0 0
Commercial paper    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents   249
Commercial paper | Quoted Prices in Active Markets for Identical Assets Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents   0
Commercial paper | Significant Other Observable Inputs Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents   249
Commercial paper | Significant Unobservable Inputs Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents   $ 0
v3.22.4
Derivative Financial Instruments (Details)
$ in Thousands
 3 Months Ended 9 Months Ended
Dec. 24, 2022
USD ($)
derivtive
Dec. 25, 2021
USD ($)
Dec. 24, 2022
USD ($)
derivtive
Dec. 25, 2021
USD ($)
Derivative Instruments, Gain (Loss) [Line Items]        
Number of foreign currency derivatives held | derivtive 1   1  
Notional value of foreign currency forward contract $ 1,100   $ 1,100  
Foreign currency forward contracts | Not Designated as Hedging Instrument        
Derivative Instruments, Gain (Loss) [Line Items]        
Gain (loss) recognized in income $ 348 $ (285) $ (447) $ (350)
v3.22.4
Accounts Receivable, net (Components of Accounts Receivable, net) (Details) - USD ($)
$ in Thousands
Dec. 24, 2022
Mar. 26, 2022
Accounts Receivable, after Allowance for Credit Loss [Abstract]    
Gross accounts receivable $ 270,493 $ 240,264
Allowance for doubtful accounts 0 0
Accounts receivable, net $ 270,493 $ 240,264
v3.22.4
Inventories (Schedule of Inventories) (Details) - USD ($)
$ in Thousands
Dec. 24, 2022
Mar. 26, 2022
Inventory Disclosure [Abstract]    
Work in process $ 112,206 $ 95,188
Finished goods 40,220 43,248
Total inventories $ 152,426 $ 138,436
v3.22.4
Revolving Credit Facility (Details) - Second Amended Credit Agreement Revolving Credit Facility - USD ($)
Jul. 08, 2021
Dec. 24, 2022
Line of Credit Facility [Line Items]    
Line of credit facility maximum borrowing capacity $ 300,000,000  
Debt covenant, exclusion of unrestricted cash and cash equivalents for ratio of consolidated funded indebtedness $ 200,000,000  
Debt covenant, maximum consolidated net leverage ratio 3.00  
Debt covenant, minimum consolidated interest coverage ratio 3.00  
Amount outstanding   $ 0
Minimum    
Line of Credit Facility [Line Items]    
Line of credit facility, unused capacity, commitment fee percentage 0.175%  
Maximum    
Line of Credit Facility [Line Items]    
Line of credit facility, unused capacity, commitment fee percentage 0.275%  
Base Rate | Minimum    
Line of Credit Facility [Line Items]    
Basis spread on variable rate 0.00%  
Base Rate | Maximum    
Line of Credit Facility [Line Items]    
Basis spread on variable rate 0.75%  
London Interbank Offered Rate (LIBOR) | Minimum    
Line of Credit Facility [Line Items]    
Basis spread on variable rate 1.00%  
London Interbank Offered Rate (LIBOR) | Maximum    
Line of Credit Facility [Line Items]    
Basis spread on variable rate 1.75%  
v3.22.4
Revenues (Summary of Product Lines) (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Dec. 24, 2022
Dec. 25, 2021
Dec. 24, 2022
Dec. 25, 2021
Disaggregation of Revenue [Line Items]        
Net sales $ 590,582 $ 548,349 $ 1,524,795 $ 1,291,488
Audio Products        
Disaggregation of Revenue [Line Items]        
Net sales 347,297 341,897 939,604 860,027
High-Performance Mixed-Signal Products        
Disaggregation of Revenue [Line Items]        
Net sales $ 243,285 $ 206,452 $ 585,191 $ 431,461
v3.22.4
Revenues (Summary of Geographic Disaggregation) (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Dec. 24, 2022
Dec. 25, 2021
Dec. 24, 2022
Dec. 25, 2021
Disaggregation of Revenue [Line Items]        
Net sales $ 590,582 $ 548,349 $ 1,524,795 $ 1,291,488
China        
Disaggregation of Revenue [Line Items]        
Net sales 397,222 384,254 1,008,967 855,772
United States        
Disaggregation of Revenue [Line Items]        
Net sales 22,140 10,341 42,439 21,697
Rest of World        
Disaggregation of Revenue [Line Items]        
Net sales $ 171,220 $ 153,754 $ 473,389 $ 414,019
v3.22.4
Revenues (Narrative) (Details)
 9 Months Ended
Dec. 24, 2022
Minimum  
Disaggregation of Revenue [Line Items]  
Product warranty, term 1 year
Maximum  
Disaggregation of Revenue [Line Items]  
Product warranty, term 3 years
v3.22.4
Income Taxes (Provision for Income Taxes) (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Dec. 24, 2022
Dec. 25, 2021
Dec. 24, 2022
Dec. 25, 2021
Income Tax Disclosure [Abstract]        
Income before income taxes $ 140,441 $ 144,009 $ 313,325 $ 260,721
Provision for income taxes $ 36,964 $ 16,373 $ 82,953 $ 30,780
Effective tax rate 26.30% 11.40% 26.50% 11.80%
v3.22.4
Income Taxes (Narrative) (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Dec. 24, 2022
Jun. 25, 2022
Dec. 25, 2021
Dec. 24, 2022
Dec. 25, 2021
Income Tax Disclosure [Abstract]          
Provision for income taxes $ 36,964   $ 16,373 $ 82,953 $ 30,780
Effective tax rate 26.30%   11.40% 26.50% 11.80%
Unrecognized tax benefits that would impact effective tax rate $ 32,900     $ 32,900  
Balance of accrued interest and penalties, net of tax $ 6,200     $ 6,200  
Estimate of possible loss   $ 170,500      
Estimate of possible loss, penalties expense   $ 63,700      
v3.22.4
Net Income Per Share (Calculation of Basic and Diluted Earnings (Loss) Per Share) (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Dec. 24, 2022
Dec. 25, 2021
Dec. 24, 2022
Dec. 25, 2021
Numerator:        
Net income $ 103,477 $ 127,636 $ 230,372 $ 229,941
Denominator:        
Weighted average shares outstanding (in shares) 55,239 57,178 55,748 57,374
Effect of dilutive securities (in shares) 1,344 1,853 1,532 1,943
Weighted average diluted shares (in shares) 56,583 59,031 57,280 59,317
Basic earnings per share (in dollars per share) $ 1.87 $ 2.23 $ 4.13 $ 4.01
Diluted earnings per share (in dollars per share) $ 1.83 $ 2.16 $ 4.02 $ 3.88
v3.22.4
Net Income Per Share (Narrative) (Details) - shares
shares in Thousands
 3 Months Ended 9 Months Ended
Dec. 24, 2022
Dec. 25, 2021
Dec. 24, 2022
Dec. 25, 2021
Earnings Per Share [Abstract]        
Weighted average shares outstanding excluded from diluted calculation (in shares) 273 102 253 97
v3.22.4
Commitment and Contingencies (Details)
$ in Millions
 9 Months Ended
Dec. 24, 2022
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
Capacity reservation fee $ 60
Amount agreed to pre-pay $ 195
v3.22.4
Stockholders' Equity (Common Stock) (Details) - shares
shares in Millions
 3 Months Ended 9 Months Ended
Dec. 24, 2022
Dec. 25, 2021
Dec. 24, 2022
Dec. 25, 2021
Stockholders' Equity Note [Abstract]        
Common stock issued as part of stock incentive plan (in shares) 0.5 0.6 0.6 0.8
v3.22.4
Stockholders' Equity (Share Repurchase Program) (Details) - USD ($)
$ / shares in Units, $ in Thousands, shares in Millions
 3 Months Ended 6 Months Ended 9 Months Ended 24 Months Ended
Dec. 24, 2022
Dec. 25, 2021
Dec. 24, 2022
Dec. 24, 2022
Dec. 25, 2021
Dec. 24, 2022
Jul. 31, 2022
Jan. 31, 2021
Equity, Class of Treasury Stock [Line Items]                
Common stock repurchased $ 49,999 $ 39,998   $ 156,382 $ 92,502      
January 2021 Repurchase Program                
Equity, Class of Treasury Stock [Line Items]                
Common stock approved under the share repurchase program               $ 350,000
Common stock repurchased 50,000     156,400   $ 313,900    
Common stock available for repurchase $ 36,100   $ 36,100 $ 36,100   $ 36,100    
Common stock repurchased (in shares) 0.7     2.0        
Average cost per share repurchased (in dollars per share) $ 70.14     $ 77.39        
July 2022 Repurchase Program                
Equity, Class of Treasury Stock [Line Items]                
Common stock approved under the share repurchase program             $ 500,000  
Common stock repurchased (in shares)     0.0          
v3.22.4
Segment Information (Details)
 9 Months Ended
Dec. 24, 2022
product_line
segment
Segment Reporting [Abstract]  
Number of reportable segments | segment 1
Number of product lines | product_line 2